Marc B. Garnick, MD

Marc B. Garnick, MD

Harvard University

Boston, MA

Marc B. Garnick, M.D., is a physician in the Division of Hematology/Oncology of the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC); serves as Director of Cancer Community Services, Network Development, BIDMC; as a Clinical Professor of Medicine at Harvard Medical School (HMS) and as a special advisor to the Oncologic Drugs Advisory Committee of the FDA. Dr. Garnick is a world-renowned clinician and clinical investigator in prostate cancer and other urologic cancers. At BIDMC, he founded the Hershey Family Program for Prostate Cancer Research. Dr. Garnick is also involved in the development of oncologic products through biotechnology. He has made it his personal mission to help patients navigate the maze of treatment options to help them make informed decisions. Dr. Garnick is editor-in-chief of The Annual Report on Prostate Diseases, Harvard Medical School’s award-winning publication and authored “The Patient’s Guide to Prostate Cancer.”

Articles by Marc B. Garnick, MD

The Role of FSH in Prostate Cancer

Marc B. Garnick, MD, discusses whether or not follicle stimulating hormone (FSH) affects prostate cancer progression and cause adverse effects when used in combination with androgen deprivation therapy (ADT). He presents evidence for both the pro and con sides of this argument.

Read More

Join the GRU Community

- Why Join? -